Kidney shield? new trial tests citrus compound for chemo patients

NCT ID NCT07598214

Recruiting now Symptom relief Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a combination of diosmin and hesperidin, natural compounds found in citrus fruits, can protect the kidneys of cancer patients receiving platinum-based chemotherapy. One hundred adults with confirmed cancer will take the supplement alongside their chemo to see if it reduces kidney damage. The goal is to ease a common side effect, not to treat the cancer itself.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: diosmin/hesperidin combination
What this could lead to: If it works, this could offer a simple way to reduce kidney damage from platinum chemotherapy, helping cancer patients tolerate treatment better.
What could go wrong: This is a small, early-phase trial with only 100 participants, so results may not apply widely. The supplement might not work or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER PATIENTS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Faculty of Medicine
RECRUITING

Banī Suwayf, 0000, Egypt

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.